2.Identification of a novel SYNGAP1 mutation in a child with intellectual disability.
Jing LU ; Yi ZHANG ; Cong HAN ; Jiayi ZHU ; Jian WANG ; Ruen YAO
Chinese Journal of Medical Genetics 2019;36(7):716-719
OBJECTIVE:
To report on a child with mental retardation caused by SYNGAP1 gene mutation.
METHODS:
Peripheral blood samples were collected from the proband and her parents. High throughput sequencing (HTS) was employed for screening for potential mutation in the patient. Suspected mutation was validated by Sanger sequencing of the child and her parents.
RESULTS:
By HTS, a previously unknown mutation [c.1656C>A (p.C552*)] was found in exon 10 of the SYNGAP1 gene in the proband. Sanger sequencing confirmed the heterozygous nature of the mutation and that neither of her parents carried the same mutation.
CONCLUSION
The dysmorphism and developmental delay of the child were probably due to the pathogenic mutation of the SYNGAP1 gene. HTS can facilitate elucidation of the genetic etiology with efficiency, which has great significance in the diagnosis, treatment and prognosis of the child.
Child
;
Exons
;
Female
;
Heterozygote
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Intellectual Disability
;
genetics
;
Mutation
;
ras GTPase-Activating Proteins
;
genetics
3.Research progress in diseases associated with genetic variants of GATOR1 complex.
Meng YUAN ; Huan LUO ; Xueyi RAO ; Jing GAN
Chinese Journal of Medical Genetics 2023;40(7):887-891
The GATOR1 complex is located at the upstream of the mTOR signal pathway and can regulate the function of mTORC1. Genetic variants of the GATOR1 complex are closely associated with epilepsy, developmental delay, cerebral cortical malformation and tumor. This article has reviewed the research progress in diseases associated with genetic variants of the GATOR1 complex, with the aim to provide a reference for the diagnosis and treatment of such patients.
Humans
;
GTPase-Activating Proteins/metabolism*
;
Signal Transduction/genetics*
;
Mechanistic Target of Rapamycin Complex 1/metabolism*
;
Epilepsy/genetics*
;
Neoplasms
4.Autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations: a report of 8 cases and literature review.
Xiao-Le WANG ; Ya-Nan TIAN ; Chen CHEN ; Jing PENG
Chinese Journal of Contemporary Pediatrics 2023;25(5):489-496
OBJECTIVES:
To summarize the clinical phenotype and genetic characteristics of children with autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations.
METHODS:
A retrospective analysis was performed on the medical data of 8 children with autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations who were diagnosed and treated in the Department of Pediatrics, Xiangya Hospital of Central South University.
RESULTS:
The mean age of onset was 9 months for the 8 children. All children had moderate-to-severe developmental delay (especially delayed language development), among whom 7 children also had seizures. Among these 8 children, 7 had novel heterozygous mutations (3 with frameshift mutations, 2 with nonsense mutations, and 2 with missense mutations) and 1 had 6p21.3 microdeletion. According to the literature review, there were 48 Chinese children with mental retardation caused by SYNGAP1 gene mutations (including the children in this study), among whom 40 had seizures, and the mean age of onset of seizures was 31.4 months. Frameshift mutations (15/48, 31%) and nonsense mutations (19/48, 40%) were relatively common in these children. In terms of treatment, among the 33 children with a history of epileptic medication, 28 (28/33, 85%) showed response to valproic acid antiepileptic treatment and 16 (16/33, 48%) achieved complete seizure control after valproic acid monotherapy or combined therapy.
CONCLUSIONS
Children with autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations tend to have an early age of onset, and most of them are accompanied by seizures. These children mainly have frameshift and nonsense mutations. Valproic acid is effective for the treatment of seizures in most children.
Child
;
Humans
;
Intellectual Disability/diagnosis*
;
Codon, Nonsense
;
Retrospective Studies
;
Valproic Acid
;
ras GTPase-Activating Proteins/genetics*
;
Mutation
;
Seizures/genetics*
5.A case of mental retardation caused by a frameshift variant of SYNGAP1 gene.
Yue SHEN ; Guanjun LUO ; Chao LU ; Yuan TAN ; Tingting CHENG ; Xuguang QIAN ; Nuo LI ; Minna LUO ; Zongfu CAO ; Xu MA ; Yong ZHAO
Chinese Journal of Medical Genetics 2023;40(1):57-61
OBJECTIVE:
To explore the genetic basis for a child with mental retardation.
METHODS:
Whole exome sequencing was carried out for the child. Candidate variant was screened based on his clinical features and verified by Sanger sequencing.
RESULTS:
The child was found to harbor a c.995_1002delAGACAAAA(p.Asp332AlafsTer84) frameshift variant in the SYNGAP1 gene. Bioinformatic analysis suggested it to be pathogenic. The same variant was not detected in either parent.
CONCLUSION
The c.995_1002delAGACAAAA(p.Asp332AlafsTer84) frameshift variant of the SYNGAP1 gene probably underlay the mental retardation in this child. Above finding has expanded the spectrum of SYNGAP1 gene variants and provided a basis for the diagnosis and treatment for this child.
Child
;
Humans
;
Intellectual Disability/genetics*
;
Frameshift Mutation
;
High-Throughput Nucleotide Sequencing
;
Computational Biology
;
Heterozygote
;
Mutation
;
ras GTPase-Activating Proteins/genetics*
7.Toxoplasma gondii infection induces cell apoptosis via multiple pathways revealed by transcriptome analysis.
Kaige DU ; Fei LU ; Chengzuo XIE ; Haojie DING ; Yu SHEN ; Yafan GAO ; Shaohong LU ; Xunhui ZHUO
Journal of Zhejiang University. Science. B 2022;23(4):315-327
Toxoplasma gondii is a worldwide parasite that can infect almost all kinds of mammals and cause fatal toxoplasmosis in immunocompromised patients. Apoptosis is one of the principal strategies of host cells to clear pathogens and maintain organismal homeostasis, but the mechanism of cell apoptosis induced by T. gondii remains obscure. To explore the apoptosis influenced by T. gondii, Vero cells infected or uninfected with the parasite were subjected to apoptosis detection and subsequent dual RNA sequencing (RNA-seq). Using high-throughput Illumina sequencing and bioinformatics analysis, we found that pro-apoptosis genes such as DNA damage-inducible transcript 3 (DDIT3), growth arrest and DNA damage-inducible α (GADD45A), caspase-3 (CASP3), and high-temperature requirement protease A2 (HtrA2) were upregulated, and anti-apoptosis genes such as poly(adenosine diphosphate (ADP)-ribose) polymerase family member 3 (PARP3), B-cell lymphoma 2 (Bcl-2), and baculoviral inhibitor of apoptosis protein (IAP) repeat containing 5 (BIRC5) were downregulated. Besides, tumor necrosis factor (TNF) receptor-associated factor 1 (TRAF1), TRAF2, TNF receptor superfamily member 10b (TNFRSF10b), disabled homolog 2 (DAB2)-interacting protein (DAB2IP), and inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) were enriched in the upstream of TNF, TNF-related apoptosis-inducing ligand (TRAIL), and endoplasmic reticulum (ER) stress pathways, and TRAIL-receptor 2 (TRAIL-R2) was regarded as an important membrane receptor influenced by T. gondii that had not been previously considered. In conclusion, the T. gondii RH strain could promote and mediate apoptosis through multiple pathways mentioned above in Vero cells. Our findings improve the understanding of the T. gondii infection process through providing new insights into the related cellular apoptosis mechanisms.
Animals
;
Apoptosis
;
Chlorocebus aethiops
;
Gene Expression Profiling
;
Humans
;
Mammals/genetics*
;
Toxoplasma/genetics*
;
Toxoplasmosis/pathology*
;
Vero Cells
;
ras GTPase-Activating Proteins/genetics*
8.Protein RAP1GAP in human myelodysplastic syndrome detected by flow cytometry and its clinical relevance.
Stella Aprilia IKA ; Xiao-Fei QI ; Zi-Xing CHEN
Journal of Experimental Hematology 2009;17(3):612-617
Previous study on the gene expression profile of human MDS by using microarray discovered that transcription of RAP1GAP was up-regulated, which was confirmed by quantitative RT-PCR in expanding cohort of MDS patients. This study was pourposed to investigate the expression of RAP1GAP in human MDS and its clinical relevance. The expression of RAP1GAP in bone marrow cells of 19 MDS patients was detected by flow cytometry and was compared with that in patients with non-malignant blood diseases and acute leukemias, meanwhile the relevance between expression level of RAP1GAP and hemoglobin, leukocytes, platelets, blasts percentage in bone marrow cells and IPSS score was analyzed. The results indicated that the expression level of RAP1GAp in MDS patients significantly increased as compared with patients with non-malignant blood diseases or AML (8.42 +/- 8.37% vs 2.97 +/- 4.75% or 2.26 +/- 4.24%). Among MDS patients, the expression level of RAP1GAP in MDS-RA was significantly higher than that in MDS-RAEB (11.64 +/- 9.07% vs 4.37 +/- 4.65%). However, no definitive correlation of expression level with above-mentioned clinical parameters was found in detected patients with DMS. In conclusion, the expression of RAP1GAP in MDS patients obviously increases, the relationship between expression level of RAP1GAP and laboratory hematological parameter and IPSS score does not be confirmed. The role played by RAP1GAP expression in the pathogenesis of MDS and its clinical significance during progression of MDS towards AML deserves further studies.
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Flow Cytometry
;
GTPase-Activating Proteins
;
genetics
;
metabolism
;
Gene Expression Profiling
;
Humans
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
genetics
;
metabolism
9.Quantification of GRAF gene expression in patients with acute myeloid leukemia using EvaGreen real time quantitative PCR.
Zhen QIAN ; Jiang LIN ; Jun QIAN ; Dong-ming YAO ; Ya-li WANG ; Lan-xiu HAN ; Zhao-hui ZHU ; Gao-fei XIAO
Chinese Journal of Medical Genetics 2010;27(3):290-293
OBJECTIVETo quantify the expression level of GRAF gene in acute myeloid leukemia (AML) and analyze its clinical significance.
METHODSThe EvaGreen real-time quantitative polymerase chain reaction (RQ-PCR) assay was established and performed to measure the GRAF gene transcripts in 71 cases with AML and 21 with nonmalignant hematological diseases. The clinical correlation of GRAF expression was analyzed.
RESULTSThe established EvaGreen RQ-PCR assay had good specificity, reproducibility and sensitivity. The GRAF expression level was significantly lower in AML (0.01%-169.75%, median 3.82%) than that in controls (14.49%-126.85%, median 56.04%) (P<0.05). There was no correlation between the level of GRAF transcript and the sex, age, hematologic parameters, FAB subtypes and karyotypic groups (P>0.05).
CONCLUSIONThe GRAF gene was down-regulated in AML, which might play a role in the leukemogenesis.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; GTPase-Activating Proteins ; genetics ; Humans ; Leukemia, Myeloid, Acute ; genetics ; Male ; Middle Aged ; Polymerase Chain Reaction ; methods ; Young Adult
10.G3BP: a promising target for cancer therapy.
Acta Pharmaceutica Sinica 2010;45(8):945-951
G3BP (Ras-GTPase-activating protein SH3 domain binding protein), a protein which binds to RasGAP SH3 domain, belongs to RNA-binding protein family, implicating in the downstream of Ras signaling. G3BP harbors the activities of endoribonuclease and DNA helicase, and can induce stress granules formation. G3BP plays a general role in the signal pathways of cell proliferation, differentiation, apoptosis and RNA metabolism. It has been shown to be over-expressed in a number of human malignancies and has a close relationship with tumor invasion and metastasis. Given that it has been implicated in several pathways that are known to be involved in cancer biology, G3BP may provide a new target for cancer therapy.
Animals
;
Carrier Proteins
;
genetics
;
metabolism
;
DNA Helicases
;
Drug Delivery Systems
;
GTPase-Activating Proteins
;
therapeutic use
;
Humans
;
Molecular Sequence Data
;
Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Peptide Fragments
;
therapeutic use
;
Phosphorylation
;
Poly-ADP-Ribose Binding Proteins
;
RNA Helicases
;
RNA Recognition Motif Proteins
;
Signal Transduction
;
ras GTPase-Activating Proteins
;
metabolism
;
src Homology Domains
;
genetics